SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001062993-17-004294
Filing Date
2017-09-28
Accepted
2017-09-28 14:18:22
Documents
1
Group Members
BALA VENKATARAMANCHRISTOPHER R. MANNINGMAYURA ONE LLCMAYURA TRUST BYELENA EPOVA

Document Format Files

Seq Description Document Type Size
1 SC 13D sc13d.htm SC 13D 91851
  Complete submission text file 0001062993-17-004294.txt   93815
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81104 | Film No.: 171106923
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE, SECOND FLOOR ALPHARETTA GA 30004
Business Address 1055B POWERS PLACE, SECOND FLOOR ALPHARETTA GA 30004 901-292-3974
AVEGO HEALTHCARE CAPITAL, LLC (Filed by) CIK: 0001718225 (see all company filings)

IRS No.: 472657122 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D